Navigation Links
Cancer Causing Chemicals Found In Urine Of Babies Whose Parents Smoke

Scientists warn that passive smokings from cigarette smoke of parents can affect their infants. The scientists have now detected the cancer-causing chemicals // , which are associated with tobacco smoke in the urine of nearly half the babies whose parents are active smokers.

"The take home message is, 'Don't smoke around your kids,'" said Stephen S. Hecht, Ph.D., professor and Wallin Chair of Cancer Prevention at The Cancer Center at the University of Minnesota.

According to a study of 144 infants, published in the May issue of Cancer Epidemiology, Biomarkers & Prevention, Hecht and his colleagues found detectable levels of NNAL* in urine from 47 percent of babies exposed to environmental tobacco carcinogens from cigarette smoking family members. NNAL is a cancer-causing chemical produced in the human body as it processes NNK**, a carcinogenic chemical specific to tobacco.

"The level of NNAL detected in the urine of these infants was higher than in most other field studies of environmental tobacco smoke in children and adults," Hecht said. "NNAL is an accepted biomarker for uptake of the tobacco-specific carcinogen NNK. You don't find NNAL in urine except in people who are exposed to tobacco smoke, whether they are adults, children, or infants."

A previous study by Hecht and his colleagues indicated that the first urine from newborns whose mothers smoked during pregnancy contained as much as one-third more NNAL compared to the babies in the current study. The newborn infants, however, took in the carcinogen directly from their mothers through their placentas rather than by breathing second-hand smoke in the air in their family homes and cars.

In the current study, when babies had detectable levels of NNAL, Hecht said that family members smoked an average of 76 cigarettes per week, in their home or car while the babies were present. In children of smokers whose babies had undetectable levels of NNAL in their
'"/>




Page: 1 2

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cancer Causing Chemicals Found Urine Babies Whose Parents Smoke

(Date:5/22/2015)... 22, 2015 Pioneer Millworks, the largest ... forefront of designing with reclaimed wood, introducing their latest ... Angeles, California. Their newest offerings, Vat 35, Reclaimed ... and color to America's largest design event. , “Designers, ... each show, anxious to see and feel the variety ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 River Valley ... Kyle Johnson, the health system’s Chief Financial Officer (CFO), ... Johnson has served as the company CFO since 2011. ... will be joining the health system as CFO. Wesley ... interim basis, while the Board of Trustees conducts a ...
(Date:5/22/2015)... Omar Ahmad Barrada, a junior at Milton ... 2015 Congress of Future Medical Leaders in Boston, Mass. ... “America’s highest achieving high school students.” , “I’m excited ... goals and learn better study habits,” said Omar. “The ... we can ask the surgeons questions.” , The goal ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 “It’s ... MS/CCC, SLP, RAC-CT, CHHRP-QT, Vice President of Clinical ... very important ‘language’ that impacts how care is ... leader in long term care reimbursement, operations and ... programs and talent management, launches a new series ...
(Date:5/22/2015)... 22, 2015 Coordinating care for ... process. Historically providers have not been reimbursed or ... in 2015, Medicare has paved the way by ... to the launch of Oculus Health , ... systems using the platform will now be able ...
Breaking Medicine News(10 mins):Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 2Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 3Health News:River Valley Health Partners Announces CFO Transition, Appointment of Interim CFO 2Health News:Milton Hershey School Student Chosen for Congress of Future Medical Leaders 2Health News:Harmony Healthcare International Takes the Lead in Launching ICD-10 Coding Transition in Post-Acute Care 2Health News:Harmony Healthcare International Takes the Lead in Launching ICD-10 Coding Transition in Post-Acute Care 3Health News:Oculus Health Care Coordination Platform Officially Launched 2Health News:Oculus Health Care Coordination Platform Officially Launched 3Health News:Oculus Health Care Coordination Platform Officially Launched 4
... By Alan Mozes HealthDay Reporter , THURSDAY, ... illness are being reported among college students than a decade ... a post-secondary education and are open to getting help when ... use of prescription medications by students to treat psychiatric illness ...
... European Urology , the official journal of the European Association ... the September issue: Case Series of the month. This series ... only preliminary results. The Case Series reports on no more ... Education question with multiple choice answers is also included to ...
... , WEDNESDAY, Aug. 11 (HealthDay News) -- A debilitating and usually ... transplant, a new study finds. , , The results may ... for the potential of stem cells in bone marrow to turn ... Aug. 12 issue of the New England Journal of Medicine ...
... nationwide research initiative has been launched to define changes in ... in response to infection or to vaccination. Six U. S.-based ... million over five years to conduct this research. ... of Allergy and Infectious Diseases (NIAID), part of the National ...
... least a quarter of patients who have suffered a stroke ... medications within the first three months after being hospitalized ... according to a new study by researchers at Wake Forest ... there are an estimated 180,000 recurrent strokes in the United ...
... Medicine,s Department of Public Health Sciences has received a ... act as the data coordinating center for the National ... one of the largest in the college,s history. AsthmaNet ... the nation that conducts clinical trials to address new ...
Cached Medicine News:Health News:College Campuses See Rise in Cases of Severe Mental Illness 2Health News:College Campuses See Rise in Cases of Severe Mental Illness 3Health News:New case series section in European Urology 2Health News:Stem Cell Treatment May Offer Hope Against Fatal Skin Disorder 2Health News:Stem Cell Treatment May Offer Hope Against Fatal Skin Disorder 3Health News:NIH launches effort to define markers of human immune responses 2Health News:1 in 4 stroke patients stop taking prevention medication within 3 months 2Health News:1 in 4 stroke patients stop taking prevention medication within 3 months 3Health News:1 in 4 stroke patients stop taking prevention medication within 3 months 4Health News:College Of Medicine receives $54 million grant for asthma research 2
(Date:5/22/2015)... May 22, 2015 Electrophysiologist Kevin Makati, ... traveled to Boston, MA ... 2015 Heart Rhythm Society conference. These scientific sessions ... on the ideas, people and technology that propel ... a hybrid, minimally invasive cardiac operation that combines ...
(Date:5/22/2015)... The North American dental lasers market ... to reach $90.7 million by 2019, at a CAGR of ... TOC of North America Dental Lasers Market for an analysis ... tables and figures. http://www.micromarketmonitor.com/market/north-america-dental-lasers-1771208223.html ...   Dental lasers are specifically used in ...
(Date:5/22/2015)... YORK , May 22, 2015  The ... of Zarxio (filgrastim-sndz) -- the first biosimilar product ... -- points toward growth in the contract ... The mainstream CMO industry is geared to the ... to produce major biopharmaceutical products. The healthcare market ...
Breaking Medicine Technology:St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 2St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 3North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 2North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4
... 5, 2007 - Synta,Pharmaceuticals Corp., (NASDAQ: SNTA) ... commercializing small,molecule drugs to treat severe medical ... of overall survival (OS) time,for patients in ... clinical trial in metastatic melanoma for its,lead ...
... 5, 2007 - Gloucester,Pharmaceuticals, Inc., a privately held ... romidepsin as a,treatment for cutaneous T-cell lymphoma (CTCL) ... American Society of,Clinical Oncology (ASCO) Annual Meeting being ... of an interim analysis of a phase II,study ...
Cached Medicine Technology:Synta Presents Results for STA-4783 in Metastatic Melanoma Showing,Improvement in Overall Survival 2Synta Presents Results for STA-4783 in Metastatic Melanoma Showing,Improvement in Overall Survival 3Synta Presents Results for STA-4783 in Metastatic Melanoma Showing,Improvement in Overall Survival 4Synta Presents Results for STA-4783 in Metastatic Melanoma Showing,Improvement in Overall Survival 5Synta Presents Results for STA-4783 in Metastatic Melanoma Showing,Improvement in Overall Survival 6Synta Presents Results for STA-4783 in Metastatic Melanoma Showing,Improvement in Overall Survival 7Gloucester Pharmaceuticals Reports Positive Interim Phase II Data,on Romidepsin for T-Cell Lymphomas at the 2007 American Society of,Clinical Oncology Annual Meeting 2Gloucester Pharmaceuticals Reports Positive Interim Phase II Data,on Romidepsin for T-Cell Lymphomas at the 2007 American Society of,Clinical Oncology Annual Meeting 3
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: